Phase 4 Study - Mucinex D as Adjunct Therapy

NCT ID: NCT00441246


Title
A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Mucinex D as Adjunct Therapy to Antibiotic Treatment of Acute Respiratory Infection
Purpose
The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.
Details
Conditions
Acute Respiratory Infection, Bronchitis, Rhinosinusitis
Keywords
Acute Respiratory Infection, Bronchitis, Rhinosinusitis
Source
Adams Respiratory Therapeutics
Sponsors
Adams Respiratory Therapeutics
Status
Completed
Acronym
Last Updated
04 Feb 2008
URL
Official Link
Locations
United States